Document is current
Any future updates will be listed below
-
Authors
Bayega, Anthony
Djambazian, Haig
Tsoumani, Konstantina T.
Gregoriou, Maria-Eleni
Sagri, Efthimia
Drosopoulou, Eleni
Mavragani-Tsipidou, Penelope
Giorda, Kristina
Tsiamis, George
Bourtzis, Kostas
Oikonomopoulos, Spyridon
Dewar, Ken
Church, Deanna M.
Papanicolaou, Alexie
Mathiopoulos, Kostas D.
Ragoussis, Jiannis https://orcid.org/0000-0002-8515-0934
-
Funding
Funding for this research was provided by:
Stavros Niarchos Foundation
Canada Foundation for Innovation (32557)
Queen Elizabeth II PhD scholarship
European Social Fund
Department of Biochemistry and Biotechnology of the University of Thessaly
Hellenic State Scholarship Foundation (MIS-5001552)
U.S. National Library of Medicine
Genome Canada (12505)
- License Information
-
More Information
Article History
Received: 12 October 2019
Accepted: 13 March 2020
First Online: 30 March 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: JR is a member of the MinION Access Program (MAP) and has received free-of-charge flow cells and sequencing kits from Oxford Nanopore Technologies for other projects. JR has had no other financial support from ONT. AB has received re-imbursement for travel costs associated with attending the Nanopore Community meeting 2018, a meeting organized by Oxford Nanopore Technologies. KG and DMC held positions as employees with 10x Genomics (Pleasanton, California, USA).
